These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24861952)

  • 21. The Relative Importance of Race Compared to Health Care and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach.
    Hanson HA; Martin C; O'Neil B; Leiser CL; Mayer EN; Smith KR; Lowrance WT
    J Urol; 2019 Dec; 202(6):1209-1216. PubMed ID: 31246547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched-pair Comparative Analysis of the Cryo On-Line Data Registry.
    Aminsharifi A; Polascik TJ; Tsivian M; Schulman A; Tsivian E; Tay KJ; Elshafei A; Jones JS
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1073-e1076. PubMed ID: 30054221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.
    Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR
    Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.
    Maurice MJ; Sundi D; Schaeffer EM; Abouassaly R
    J Urol; 2017 Mar; 197(3 Pt 1):627-631. PubMed ID: 27582435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system.
    Riviere P; Luterstein E; Kumar A; Vitzthum LK; Deka R; Sarkar RR; Bryant AK; Bruggeman A; Einck JP; Murphy JD; Martínez ME; Rose BS
    Cancer; 2020 Apr; 126(8):1683-1690. PubMed ID: 31984482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Sundi D; Ross AE; Humphreys EB; Han M; Partin AW; Carter HB; Schaeffer EM
    J Clin Oncol; 2013 Aug; 31(24):2991-7. PubMed ID: 23775960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
    Urology; 2014 Aug; 84(2):386-92. PubMed ID: 24975710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of surgical margin status on prostate-cancer-specific mortality.
    Chalfin HJ; Dinizo M; Trock BJ; Feng Z; Partin AW; Walsh PC; Humphreys E; Han M
    BJU Int; 2012 Dec; 110(11):1684-9. PubMed ID: 22788795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis.
    Cirulli GO; Davis M; Stephens A; Chiarelli G; Finati M; Corsi N; Williams E; Affas R; Sood A; Buffi N; Lughezzani G; Carrieri G; Salonia A; Briganti A; Montorsi F; Rogers C; Abdollah F
    J Urol; 2024 Oct; 212(4):560-570. PubMed ID: 39079152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer.
    Mahal BA; Aizer AA; Efstathiou JA; Nguyen PL
    Cancer; 2016 Jan; 122(1):78-83. PubMed ID: 26371600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
    Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
    Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
    Faisal FA; Kaur HB; Tosoian JJ; Tomlins SA; Schaeffer EM; Lotan TL
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):552-559. PubMed ID: 30850708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
    Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
    Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.
    Butler SS; Mahal BA; Lamba N; Mossanen M; Martin NE; Mouw KW; Nguyen PL; Muralidhar V
    Cancer; 2019 Sep; 125(18):3164-3171. PubMed ID: 31150125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.